Techniques for encapsulating bioactive agents into liposomes.
暂无分享,去创建一个
[1] M. Bally,et al. Generation of multilamellar and unilamellar phospholipid vesicles , 1986 .
[2] M. Bally,et al. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. , 1986, Biochimica et biophysica acta.
[3] J. Crowe,et al. Preservation of freeze-dried liposomes by trehalose. , 1985, Archives of biochemistry and biophysics.
[4] R. Lenk,et al. Liposome-collagen gel matrix: a novel sustained drug delivery system. , 1985, Journal of pharmaceutical sciences.
[5] R. Lenk,et al. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. , 1985, The Journal of infectious diseases.
[6] H. Miura,et al. Evaluation of a new liposome preparation technique, the freeze-thawing method, using L-asparaginase as a model drug. , 1985, Chemical & pharmaceutical bulletin.
[7] L. Mayer,et al. Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. , 1985, Biochimica et biophysica acta.
[8] M. Bally,et al. Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. , 1985, Biochimica et biophysica acta.
[9] T. Tadakuma,et al. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes , 1985, Antimicrobial Agents and Chemotherapy.
[10] M. Bally,et al. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. , 1985, Biochimica et biophysica acta.
[11] S M Gruner,et al. Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. , 1985, Biochemistry.
[12] I. Fidler,et al. The potential use of liposome-mediated antiviral therapy , 1985, Antiviral Research.
[13] I. Bakker-Woudenberg,et al. Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. , 1985, The Journal of infectious diseases.
[14] H. Patel. Liposomes as a controlled-release system. , 1985, Biochemical Society transactions.
[15] J. Reuben,et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. , 1985, The Journal of infectious diseases.
[16] G. Gregoriadis,et al. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. , 1985, Biochimica et biophysica acta.
[17] P. Schein,et al. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. , 1985, Cancer research.
[18] M. Bally,et al. Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential. , 1985, The Journal of biological chemistry.
[19] M. Bally,et al. Uptake of safranine and other lipophilic cations into model membrane systems in response to a membrane potential , 1985 .
[20] M. Bally,et al. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.
[21] E. Hersh,et al. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. , 1984, The Journal of infectious diseases.
[22] G. Scherphof,et al. On the size-dependent disintegration of small unilamellar phosphatidylcholine vesicles in rat plasma. Evidence of complete loss of vesicle structure. , 1984, The Biochemical journal.
[23] J. Hadgraft,et al. The in vivo release of cortisone esters from liposomes and the intramuscular clearance of liposomes , 1984 .
[24] H. Miura,et al. A novel method for preparing liposome with a high capacity to encapsulate proteinous drugs: freeze-drying method. , 1984, Chemical & pharmaceutical bulletin.
[25] G. Gregoriadis,et al. Role of lipoproteins in stability and clearance of liposomes administered to mice. , 1984, Biochemical Society Transactions.
[26] J. Graybill,et al. Treatment of experimental murine candidiasis with liposome-associated amphotericin B. , 1984, Sabouraudia.
[27] S. Seltzer,et al. Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications. , 1984, Investigative radiology.
[28] C. Hunt,et al. Liposome disposition in vivo. VI: Delivery to the lung. , 1984, Journal of pharmaceutical sciences.
[29] J. Weinstein,et al. Liposomes as drug carriers in cancer chemotherapy. , 1984, Pharmacology & therapeutics.
[30] E. Hersh,et al. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. , 1983, The Journal of infectious diseases.
[31] G. Poste. Liposome targeting in vivo: Problems and opportunities , 1983 .
[32] S. Sieber,et al. Carrier activity of sonicated small liposomes containing melphalan to regional lymph nodes of rats. , 1983, Pharmacology.
[33] Y. Barenholz,et al. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. , 1982, Cancer research.
[34] G. Gregoriadis,et al. Is half‐life of circulating liposomes determined by changes in their permeability? , 1982, FEBS letters.
[35] J. Graybill,et al. Amphotericin B in liposomes: a novel therapy for histoplasmosis. , 1982, The American review of respiratory disease.
[36] J. Graybill,et al. Treatment of murine cryptococcosis with liposome-associated amphotericin B. , 1982, The Journal of infectious diseases.
[37] F. Szoka,et al. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. , 1982, European journal of cancer & clinical oncology.
[38] C. Hunt,et al. Liposome disposition in vivo II: Dose dependency. , 1982, Journal of pharmaceutical sciences.
[39] C. Hunt,et al. Liposome disposition in vivo. III. Dose and vesicle-size effects. , 1981, Biochimica et biophysica acta.
[40] E. L. Springer,et al. Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. , 1981, Biochemistry.
[41] U. Pick,et al. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. , 1981, Archives of biochemistry and biophysics.
[42] S. Kaye. Liposomes--problems and promise as selective drug carriers. , 1981, Cancer treatment reviews.
[43] G. Zampighi,et al. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. , 1981, Biochemistry.
[44] G. Gregoriadis,et al. The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation , 1980, FEBS letters.
[45] C. Alving,et al. Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. , 1980, Life sciences.
[46] G. Gregoriadis,et al. Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum , 1980, FEBS letters.
[47] G. Gregoriadis,et al. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.
[48] F. Szoka,et al. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. , 1979, Biochimica et biophysica acta.
[49] G. Weissmann,et al. Enzyme replacement via liposomes. Variations in lipid compositions determine liposomal integrity in biological fluids. , 1979, Biochimica et biophysica acta.
[50] S. Amselem,et al. A new method for preparation of phospholipid vesicles (liposomes) ‐ french press , 1979, FEBS letters.
[51] D. Deamer,et al. Liposomes from ionic, single-chain amphiphiles. , 1978, Biochemistry.
[52] D. Lavelle,et al. Evidence for translation of rabbit globin mRNA after liposomemediated insertion into a human cell line , 1978, Nature.
[53] J. Parks,et al. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. , 1978, Biochimica et biophysica acta.
[54] G. Weissmann,et al. Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses. , 1978, Biochimica et biophysica acta.
[55] P. C. Hinkle,et al. Reconstitution and purification of the D-glucose transporter from human erythrocytes. , 1977, The Journal of biological chemistry.
[56] H. Hauser,et al. Single bilayer vesicles prepared without sonication. Physico-chemical properties. , 1976, Biochimica et biophysica acta.
[57] D. Deamer,et al. Catecholamine uptake and concentration by liposomes maintaining p/ gradients. , 1976, Biochimica et biophysica acta.
[58] A. Chobanian,et al. The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat. , 1976, Biochemical and Biophysical Research Communications - BBRC.
[59] D. Deamer,et al. Large volume liposomes by an ether vaporization method. , 1976, Biochimica et biophysica acta.
[60] M. W. Hill,et al. Preparation and Use of Liposomes as Models of Biological Membranes , 1974 .
[61] G Gregoriadis,et al. Drug entrapment in liposomes , 1973, FEBS letters.
[62] G. Gregoriadis,et al. Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. , 1972, The Biochemical journal.
[63] G. Gregoriadis,et al. Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. , 1972, European journal of biochemistry.
[64] Ching-Hsien Huang,et al. Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .
[65] D. Papahadjopoulos,et al. Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. , 1967, Biochimica et biophysica acta.